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Abstract
The liver plays a vital role in glucose homeostasis, the synthesis of bile acids and the detoxification of foreign substances.
Liver culture systems are widely used to test adverse effects of drugs and environmental toxicants. The two most prevalent
liver culture systems are hepatocyte monolayers (HMs) and collagen sandwiches (CS). Despite their wide use,
comprehensive transcriptional programs and interaction networks in these culture systems have not been systematically
investigated. We integrated an existing temporal transcriptional dataset for HM and CS cultures of rat hepatocytes with a
functional interaction network of rat genes. We aimed to exploit the functional interactions to identify statistically significant
linkages between perturbed biological processes. To this end, we developed a novel approach to compute Contextual
Biological Process Linkage Networks (CBPLNs). CBPLNs revealed numerous meaningful connections between different
biological processes and gene sets, which we were successful in interpreting within the context of liver metabolism.
Multiple phenomena captured by CBPLNs at the process level such as regulation, downstream effects, and feedback loops
have well described counterparts at the gene and protein level. CBPLNs reveal high-level linkages between pathways and
processes, making the identification of important biological trends more tractable than through interactions between
individual genes and molecules alone. Our approach may provide a new route to explore, analyze, and understand cellular
responses to internal and external cues within the context of the intricate networks of molecular interactions that control
cellular behavior.
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Introduction
The liver is one of the important organs in our bodies, playing a
vital role in glucose homeostasis, the synthesis of bile acids for the
metabolism of cholesterol, and the secretion of proteins to aid
clotting [1]. Additionally, the liver is primarily responsible for the
detoxification of foreign substances, including a variety of
environmental toxicants, alcohol, cigarette smoke, and drugs [1].
Hepatocytes are the principal cells in the liver, comprising over
80% of its mass and performing several characteristic functions of
this organ. Liver culture systems such as hepatocyte monolayers
(HMs) and collagen sandwiches (CSs) are routinely used to test
adverse effects of drugs and environmental toxicants. In HMs,
hepatocytes are cultured on a single collagen gel. Such cells
progressively lose their phenotypic characteristics over time [2]. In
CS systems, hepatocytes are maintained between two collagen
gels. Hepatocytes in CS cultures remain stable over extended
periods of time, and maintain differentiated hepatic functions
[3,4]. While morphological and physiological characteristics of
hepatocytes in CS cultures have been studied extensively,
comprehensive transcriptional studies of these culture systems do
not appear to have been reported. Therefore, in an earlier study,
we performed a systematic temporal study of genome-wide gene
expression programs in HMs and in CS cultures over an eight-day
period [5]. We used Gene Set Enrichment Analysis (GSEA) [6] to
compare the transcriptional programs in the two culture systems.
Our results demonstrated that gene expression in hepatocytes in
CS cultures steadily and comprehensively diverges from that in
HMs [5]. Gene sets up-regulated in CS cultures included several
hepatic functions, such as metabolism of lipids, amino acids,
carbohydrates, and alcohol, and synthesis of bile acids. Monoox-
ygenases such as Cytochrome-P450 enzymes did not show any
change between the culture systems after one day, but exhibited
significant up-regulation in CS cultures after three days and later
in comparison to HMs.
This analysis did not consider the fact that a cell’s response to
its environment is governed by an intricate network of molecular
interactions. These interactions dynamically change in response
to a myriad of cues. Therefore, discovering the set of molecular
interactions that are active in a given cellular context is a
fundamental question in computational systems biology [7]. In
the current work, we reanalyze the CS-HM transcriptional data
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propose a novel approach called ‘‘Contextual Biological Process
Linkage Network’’ (CBPLN) that focuses on computing which
processes in the cell are perturbed in a particular context and
how these processes are linked to each other. Our approach is
predicated on the belief that high-level linkages between path-
ways and processes make identification of important biological
trends more tractable and intuitive than through interactions
between individual genes and molecules alone. Our method
requires three inputs:
1. p-values representing the statistical significance of the differ-
ential expression of each gene (upon comparing a treatment to
a control), which we refer to hereafter as expression p-values,
2. a functional or physical interaction network connecting genes
and proteins, and
3. a dataset of functional annotations for genes and proteins.
We extend the method developed by Dotan-Cohen et al. [8] to
detect directed linkages between gene sets in the context of a
functional interaction network. Given two biological processes a
and b and the sets of genes that are members of each, these
authors computed the number of genes annotated by b that are
themselves not annotated by a and interact with at least one gene
annotated by a. They estimated the statistical significance of this
count using the one-sided version of Fisher’s exact test. Similar
methods developed by Pandey et al. [9,10] for regulatory and
physical interaction networks are aimed at discovering chains of
significantly linked biological processes.
In this work, we extend the ideas of Dotan-Cohen et al. to
incorporate gene expression measurements to determine which
inter-process links are significantly perturbed between the
measured conditions. Informally, we compute a score for a link
from process a to process b based upon the expression p-values of
pairs of interacting genes, where one gene belongs to process a and
the other to process b. Our score takes estimates of confidence in
the interactions into account. High-confidence interactions with
highly perturbed incident genes make large contributions to the
score. We estimate the statistical significance of the score by
computing an empirical distribution of scores under two different
hypotheses. The first hypothesis tests the dependence of the score
on the particular set of genes annotated by b, i.e., it asks if we
would observe a particular score from process a to b even if we
selected the genes annotated by b uniformly at random from the
set of all annotated genes. This test directly extends the approach
used by Dotan-Cohen et al. The second hypothesis tests the
dependence of the score on the specific interactions in the network,
i.e., it asks if we would observe the score from a to b even with an
interaction network drawn from a distribution of networks with
the same node degrees. Under either hypothesis, we report the
significance of the link, after multiple testing correction, as a p-
value. Hereafter, we refer to this quantity as the link p-value,t o




Gene Expression Data. We used the Affymetrix Rat
Genome 230 2.0 GeneChip to measure genomewide trans-
criptional profiles in rat hepatocytes grown in monolayers and in
collagen sandwiches [5]. This dataset is available in MIAME-
compliant format in the Gene Expression Omnibus (accession
number GSE20659). We marked the day when we deposited the
second layer of collagen in CS cultures as day zero. On days one,
two, three and eight after deposition of the second layer of
collagen, we measured data in triplicate in hepatocytes in each
culture system.
Functional Linkage Network. Existing databases of protein
interactions contain very few experimentally detected Protein-
Protein Interactions (PPIs) for rat: seven different widely-used
sources [11–17] contained a total of just 1,274 non-redundant rat
PPIs spanning 974 proteins. Therefore, we decided to use the rat
functional linkage network predicted by the STRING system [18].
The interaction type in STRING is a functional association, which the
authors define as ‘‘the specific and meaningful interaction between
two proteins that jointly contribute to the same functional process.’’
Apart from incorporating experimental interaction data, STRING
uses multiple methods to predict possible functional linkages
including interolog-based interaction transfer, similar transcrip-
tional response across a variety of conditions (co-expression), text-
mining, and gene families that share above-random similarities in
their evolutionary histories. STRING includes a scheme to score
eachpredicted interactionintherange150–1000againstacommon
reference of functional partnership based on the KEGG database
[19]. STRING version 8.3, released on May 26, 2010 contains
975,454 predicted interactions among 15,178 rat proteins. We used
the subset of these interactions with a weight of at least 500; there
were 204,992 such interactions among 9,925 proteins. We selected
500 as a cutoff based on the reasoning that interactions with at least
this weight were more likely to connect genes belonging to the same
process than to connect genes belonging to different processes.
When we further pruned the network to include genes with at least
one annotation (see below), we obtained 47,002 interactions among
4,714 genes.
Functional Annotations. In our earlier work [5], we used
GSEA to compare the two culture systems at each of the four time
points; Table 1 lists the contrasts we analyzed. This analysis
provided insights into the temporal patterns of up- and down-
regulation in the gene sets in the Molecular Signature Database
(MSigDB) [6]. In that work, we focused our analysis on gene sets
that showed monotonically diverging patterns of expression
between CS and HM cultures. In the current paper, we use the
curated (c2), motif (c3), and Gene Ontology (c5) collections of gene
sets in MSigDB as our set of functional annotations. We focus on
establishing linkages among the subset of 18 up-regulated gene sets
from the previous study; Table 2 lists these sets along with a short
description of each.
Overview of Results
We considered only those links with a link p-value of at most
0:01, after using the method of Benjamini and Hochberg [20] to
adjust for testing multiple hypotheses. We further restricted our
attention to pairs of gene sets for which at least 10 genes
exclusively in the second set of the pair interacted with genes in the
first set, reasoning that fewer interacting genes might not yield
robust link p-values. We compared the number of links computed
by using each hypothesis test. We also compared these values to
the number of links in the (context-free) BPLN computed using the
method of Dotan-Cohen et al. [8]. Tables 3 and 4 display the
results of the comparisons.
Several salient trends emerged. First, in Table 3, irrespective of
the hypothesis test used, the number of links increased with time.
This phenomenon parallels our earlier observation that the
transcriptional programs of hepatocytes in CS cultures steadily
diverged from that in HMs. Second, the size of the intersection
between the two sets of links also increased with time, as did the
Jaccard similarity coefficient of the two sets (i.e., the size of the
Networks of Perturbed Biological Processes
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day, the number of links deemed to be significant by both
hypothesis tests was itself statistically significant, based on Fisher’s
Exact Test (see File S1). These trends suggest that once the
transcriptional programs of the two culture systems have diverged
(day 2 and later), both hypothesis tests find very similar sets of
process pairs to be significantly linked at the 0.01 level. However,
the number of common links is very close to the number of links
identified by the second hypothesis test, indicating that the second
test is more conservative than the first in deciding whether a link is
statistically significant. We observed similar results when we
repeated these analyses with other cutoffs on the link p-value
(0.005, 0.05, and 0.1) (see File S2). Third, normalizing the linkage
score (see ‘‘Methods’’) pruned out a small number of links.
Finally, the overlap between the intersection of the results from
both hypothesis tests and the BPLN was small in days 1 and 2 and
more substantial in days 3 and 8 (Table 4), although the overlap
was still statistically significant by Fisher’s Exact Test (see File S1).
These data suggest that only a subset of the links in a BPLN may
have some relevance to the particular biological conditions being
investigated. By incorporating measurements of gene expression,
CBPLNs can identify those inter-process links that correspond to
the phenotypic differences observed in the two conditions being
compared (e.g., hepatocytes in CS versus HM).
Although both hypothesis tests find very similar sets of process
pairs to be significantly linked at the 0.01 level, especially in later
days, we found that the actual link p-values computed for each
process pair were not very highly correlated to each other (see File
S3). Based on these results, we decided to consider a linkage
betweena pair ofgene setsonly if thislinkwas significant at the0.01
level with both hypothesis tests with normalization. The resulting
CBPLNs are displayed in Figures 1, 2, 3, 4. For reference, we have
displayed the BPLN in Figure 5. We discuss the properties of these
CBPLNs in the rest of the paper. We focus primarily on the day 8
Table 1. Contrasts analyzed for contextual BPLNs.
Contrast name Treatment Control
CS vs. HM 1d Collagen sandwich 1 day Hepatocyte monolayer 1 day
CS vs. HM 2d Collagen sandwich 2 days Hepatocyte monolayer 2 days
CS vs. HM 3d Collagen sandwich 3 days Hepatocyte monolayer 3 days
CS vs. HM 8d Collagen sandwich 8 days Hepatocyte monolayer 8 days
doi:10.1371/journal.pone.0015247.t001
Table 2. Gene sets from MSigDB selected for our analyses.
MSigDB gene set name Description
ALCOHOL_METABOLIC_PROCESS (GO BP) reactions and pathways involving alcohols
CARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY (GO MF) transfer of carboxylic acid across a membrane
CELLULAR_LIPID_METABOLIC_PROCESS (GO BP) lipid reactions and pathways
GLYCOLYSIS_AND_GLUCONEOGENESIS participation in glycolysis or gluconeogenesis
HSA00071_FATTY_ACID_METABOLISM KEGG fatty acid metabolism pathways
HSA00120_BILE_ACID_BIOSYNTHESIS KEGG bile acid synthesis genes
HSA00220_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS KEGG urea cycle and metabolism and amino groups
pathways
HSA00251_GLUTAMATE_METABOLISM KEGG glutamate metabolism pathways
HSA00980_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 KEGG pathways for metabolism of xenobiotics by
cytochrome P450
HSA03320_PPAR_SIGNALING_PATHWAY KEGG PPAR signaling pathway
HSIAO_LIVER_SPECIFIC_GENES liver tissue genes
HUMAN_TISSUE_LIVER genes specifically expressed in human liver tissue rather
than mouse
MONOOXYGENASE_ACTIVITY (GO MF) integration of one oxygen atom into a
compound
NITROGEN_COMPOUND_CATABOLIC_PROCESS (GO BP) pathways for breakdown of nitrogenous
compounds
NITROGEN_COMPOUND_METABOLIC_PROCESS (GO BP) pathways for synthesis and breakdown of
nitrogenous compounds
NUCLEAR_RECEPTORS GenMAPP nuclear receptor genes
PEROXISOME (GO CC) associated with peroxisome
V$HNF1_Q6 genes containing promoter motif for hepatic nuclear
factor
doi:10.1371/journal.pone.0015247.t002
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also apparent in the day 3 CBPLN (Figure 3). When we discuss
some pairs of linked gene sets, we refer to the underlying functional
interaction network connecting the genes in those sets. We start by
discussing properties of liver-specific genes, focusing particularly on
the regulation of these genes by the transcription factor HNF1.
Then, we discuss the role of lipid homeostasis and bile acid
synthesis in the liver. Finally, we summarize the different
interpretations of the links in CBPLNs. We stress that the
formulation of linkage between processes a and b is asymmetric.
Hence, by definition, links in the CBPLN are directed, i.e., a
CBPLN may contain a link between a and b and between b
and a.
Liver Specific Genes
The 251 genes in the HSIAO_LIVER_SPECIFIC_GENES
gene set are expressed selectively in the liver, as determined by
Hsiao et al. [21] from a compendium of gene expression in normal
human tissues created with the goal of defining a reference for
basic organ systems biology. Genes in this set are members of a
spectrum of biological processes, including fatty acid metabolism,
metabolism of xenobiotics, blood coagulation, and response to
wounding. Not surprisingly, this gene set occupies a central place
in the CBPLN on day 8 (Figure 4); it has the highest number of
outgoing and incoming links. Outgoing links include connections
to glycolysis and gluconeogenesis, alcohol metabolism process,
metabolism of xenobiotics by cytochrome P450s, the Peroxisome
Proliferator-Activated Receptor (PPAR) signaling pathway, lipid
metabolic processes, the urea cycle, and bile acid biosynthesis,
among others. In turn, the gene sets such as V$HNF1_Q6 and
NUCLEAR_RECEPTORS are linked to HSIAO_LIVER_SPE-
CIFIC_GENES. Some links involving HSIAO_LIVER_SPECI-
FIC_GENES are unidirectional on day 2 or day 3 (Figures 2 and
3) but bidirectional on day 8 (Figure 4), e.g., to HSA03320_
PPAR_SIGNALING_PATHWAY and metabolism of fatty acids,
bile acids, and alcohol. Such features suggest that CBPLNs may be
representing cellular signals emanating from a subset of liver
specific genes to other processes and subsequent feedback from the
Table 3. Comparison of the properties of the CBPLNs computed by using each hypothesis test.













Day 1 32 21 21 0.66 28 17 17 0.61
Day 2 39 30 30 0.77 33 27 27 0.82
Day 3 75 54 53 0.70 70 52 51 0.72
Day 8 96 81 79 0.81 94 77 75 0.78
There are two groups of columns, one for the results without normalization and another for the results with normalization, where ‘‘normalization’’ refers to results
obtained when we deduct the score calculated with average expression values from the observed score. Within each group, the columns titled ‘‘Gene set
randomization’’ refer to the number of observed significant links (corrected link p-value ƒ0:01) when we construct the null distribution by re-sampling the genes
annotated with the gene set b; similarly, the columns titled ‘‘Network randomization’’ refer to the number of significant links observed when generating interaction
networks with the same node degrees as the original network. The columns titled ‘‘Intersection’’ refer to the number of links significant under both hypothesis tests. The
column titled ‘‘Jaccard index’’ contains the ratio of the size of the intersection to the size of the union of the CBPLNs computed by the two hypothesis tests. File S1
contains the statistical significance values for the intersection sizes, as computed by Fisher’s exact test.
doi:10.1371/journal.pone.0015247.t003
Table 4. Comparison of the number of links in the BPLN to the number of links in the CBPLNs, computed without and with
normalization.
BPLN Gene set randomization Intersection Jaccard index Network randomization Intersection Jaccard index
Without normalization
Day 1 105 32 32 0.30 21 21 0.20
Day 2 105 39 39 0.37 30 30 0.29
Day 3 105 75 75 0.71 54 53 0.50
Day 8 105 96 93 0.86 81 79 0.74
With normalization
Day 1 105 28 28 0.27 17 17 0.16
Day 2 105 33 33 0.31 27 27 0.26
Day 3 105 70 70 0.67 52 51 0.48
Day 8 105 94 91 0.84 77 75 0.70
The column titled ‘‘BPLN’’ denotes the number of links in the BPLN. Note that the number of links in the BPLN does not change with the number of days, as the BPLN
method does not use gene expression data. The last six columns are divided into two groups of three columns each. The first set of columns compare BPLNs to CBPLNs
computed using gene set randomization. The second set of columns compare BPLNs to CBPLNs computed using network randomization. The data in and meaningo f
columns ‘‘Gene set randomization’’ and ‘‘Network randomization’’ are identical to those in Table 3. The columns titled ‘‘Intersection’’ contains the number of links found
to be significant in both the BPLN and the respective CBPLN. The columns ‘‘Jaccard index’’ contains the ratio of the size of the intersection to the size of the union of the
BPLN and the respective CBPLN. Statistical significance values for the intersection sizes, as computed by Fisher’s exact test, are available in File S1.
doi:10.1371/journal.pone.0015247.t004
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that CBPLNs can assist in the sub-division of liver-specific genes
into more refined categories, based not only on the functions of the
genes themselves, but also on how they are regulated and what
other processes they may control. We discuss one specific link next
that illustrates this property.
Figure 1. CS vs. HM CBPLN on day 1. In this figure and all other figures displaying CBPLNs, each node is one of the gene sets in Table 2. An edge
connects two gene sets whose linkage is determined to be statistically-significant by both hypothesis tests used in computing CBLPNs. The color of a
node indicates the statistical significance of its perturbation, as computed by GSEA [6]. The legend mapping colors to ranges of statistical significance
appears at the bottom of the figure. We use the same color scheme to indicate the statistical significance computed for a gene set by GSEA and for
the significance value computed for a gene by LIMMA. We use this color scheme in all the subsequent figures as well.
doi:10.1371/journal.pone.0015247.g001
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Hepatic nuclear factor 1 (HNF1), also known as albumin proximal
factor, is a transcription factor required for the expression of several
liver-specific genes including albumin [22]. The protein functions as a
homodimer and binds to the inverted palindrome 59-GTTAAT-
NATTAAC-39. The promoter regions of genes in the MSigDB set
V$HNF1_Q6 match this binding site for HNF1 [23]. In our previous
study [5], we noted the monotonic up-regulation of this gene set in
CS cultures when compared to HMs. This gene set has an overlap of
25 genes with the gene set HSIAO_LIVER_SPECIFIC_GENES.
We concluded that HNF1 monotonically up-regulates the expression
of liver-specific genes in CS cultures but not in HMs.
CBPLNs assist us in elaborating upon these earlier observations.
We studied the link between V$HNF1_Q6 and HSIAO_
LIVER_SPECIFIC_GENES in the day 8 CBPLN by examining
the functional interactions in the STRING database connecting
genes in V$HNF1_Q6 to genes in HSIAO_LIVER_SPECIFIC_
GENES. Figure 6 displays a layout of this network. Visual
examination of Figure 6 indicates that the linkage between these
two gene sets is driven by the genes F2, Plg, CYP2E1, Nr1h4,
Lipc, and their interactors, with weaker contributions arising from
Hnf1a and Hnf4a. Note that F2, Plg, CYP2E1, Nr1h4, and Lipc
are members of both gene sets while Hnf1a and Hnf4a are
members of V$HNF1_Q6. We discuss a subset of these proteins
next, highlighting liver-specific processes they participate in.
HNF1a and HNF4a. Hepatocyte nuclear factor 4a (Hnf4a) is
a nuclear receptor implicated in the regulation of numerous genes
associated with hepatic function [24–26], gluconeogenesis [27],
and activation of the metabolism of xenobiotics, including drugs
and pharmaceuticals [28]. It is known that both the HNF4 protein
and HNF1 protein can transactivate the HNF1 gene [29].
Although both genes are not very highly up-regulated, their
Figure 2. CS vs. HM CBPLN on day 2.
doi:10.1371/journal.pone.0015247.g002
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Slc2a2, Slc10a1, Fabp1, and Pck1 suggest the activation of many
liver-related pathways.
Blood clotting (Plg and F2). Plasminogen (Plg) is a secreted
protein that is proteolysed to plasmin and angiostatin. Plasmin
dissolves fibrin in blood clots while angiostatin inhibits
angiogenesis. In Figure 6, the significantly up-regulated genes
that Plg interacts with include the serpin peptidase inhibitors
Serpina1 and Serpinf2, kallikrein B (Klkb1), and coagulation
factor XII (F12). Another important protein in Figure 6 is the
prothrombin precursor (Coagulation factor II, F2), which interacts
with F10, Fga, Fgg, Fn1, Proc, Serpina5, Serpind1, and Vtn. Most
of the interactions involving Plg and F2 have been included in
STRING via the KEGG pathway for complement and
coagulation cascades [19]. The complement system and blood
coagulation are a closely interacting pair of proteolytic cascades in
blood plasma that are activated after injury [30]. The blood
coagulation cascade culminates in the formation of thrombin, the
enzyme responsible for the conversion of soluble fibrinogen to the
insoluble fibrin clot.
Metabolism of xenobiotics (CYP2E1). Cytochrome P450,
family 2, subfamily E, polypeptide 1 (CYP2E1) encodes a member
of the cytochrome P450 superfamily of enzymes. Cytochrome
P450s proteins are monooxygenases, which carry out the liver’s
prominent role in xenobiotic metabolism and synthesis of
cholesterol, steroids and other lipids. CYP2E1 is an important
member of this family, implicated in the metabolism of exogenous
compounds such as benzene, carbon tetrachloride, ethylene glycol,
and substances found in cigarette smoke as well as endogenous
compounds including ethanol, acetone, and acetal [31–33]. In
Figure 6, CYP2E1 interacts with C2, Cyb5a, CYP4F1, Ephx1,
and Mgst1. The interactions of CYP2E1 with Cytochrome P450
Figure 3. CS vs. HM CBPLN on day 3.
doi:10.1371/journal.pone.0015247.g003
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glutathione S-transferase 1 (Mgst1) are included in the KEGG
pathways for metabolism of xenobiotics by Cytochrome P450s and
for Arachidonic acid metabolism, which are sources of interactions
for STRING. Further support for the role played by CYP2E1
comes from the links to HSA00980_METABOLISM_OF_
XENOBIOTICS_BY_CYTOCHROME_P450 from V$HNF1_
Q6 and HSIAO_LIVER_SPECIFIC_GENES in the day 8
CBPLN (Figure 4). These links are mediated by the functional interac-
tions between CYP2E1 and members of the alcohol dehydrogenase
and glutathione s-transferase gene families (data not shown).
Lipid Homeostasis and Bile Acid Synthesis
Two of the most important functions that hepatocytes in the
liver carry out are lipid homeostasis and bile acid synthesis. These
two functions are intrinsically linked. As illustrated schematically
in Figure 7, the liver produces bile acids, which are secreted into
the small intestine, where they allow for breakdown of dietary fats
and uptake of fatty acids. Subsequently, the liver re-mobilizes these
fatty acids throughout the body via lipoproteins [34]. Lipoproteins
circulate fatty acids and cholesterol through the body in a cycle
that begins with the liver’s secretion of fatty acid-rich very low-
density lipoproteins (VLDLs) and ends with the liver’s uptake of
cholesterol-rich high-density lipoproteins (HDLs) [35]. The liver
then recycles these cholesterols or converts them into bile acids.
Our results capture the high-level relationships between these
processes, as displayed in the sub-CBPLNs involving nuclear
receptors, the PPARa signaling pathway, bile acid biosynthesis,
and fatty acid metabolism (Figures 8A–8D).
Before we examine some of these links in more detail, we stress
that the links in CBPLNs (e.g., the bi-directional links between
HSA03320_PPAR_SIGNALING_PATHWAY and HSA00120_
Figure 4. CS vs. HM CBPLN on day 8.
doi:10.1371/journal.pone.0015247.g004
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tion. Both HSA03320_PPAR_SIGNALING_PATHWAY and
HSA00120_BILE_ACID_BIOSYNTHESIS are up-regulated in
CS cultures in contrast to HMs (Fig. 8C and Fig. 8D). Bile acids
directly induce the expression of PPARa [36], which supports
interpreting the observed link from HSA00120_BILE_ACID_
BIOSYNTHESIS to HSA03320_PPAR_SIGNALING_PATH-
WAY as a regulatory one. On the other hand, although it is
tempting to infer that the reverse of that link, from HSA03320_
PPAR_SIGNALING_PATHWAY to HSA00120_BILE_ACID_
BIOSYNTHESIS, also implies the PPARa pathway up-regulates
bile acid biosynthesis, such a conclusion may be incorrect. Since
the up-regulation trends arise from the comparison of CS cultures
to HMs, it is possible that bile acid production in CS cultures is
constant (or even decreasing) over time and that bile acid levels in
HMs are decreasing. In fact, when we compare the expression
values of these two gene sets exclusively within the CS cultures, we
observe that there is no statistically significant change between the
expression levels of the bile acid biosynthesis genes between days 3
and 8, and that there is a barely statistically significant up-
regulation of the genes in the PPARa signaling pathway between
the same two days (data not shown). Moreover, PPARa has been
shown to directly inhibit production of Cholesterol 7a-hydroxylase
(CYP7A1) [37,38]. CYP7A1 is the rate-limiting enzyme in the
classical pathway of bile acid synthesis from cholesterol [35].
Therefore, while we can conclude from the CBPLN that
HSA03320_PPAR_SIGNALING_PATHWAY may regulate
HSA00120_BILE_ACID_BIOSYNTHESIS, the mode of regula-
tion (e.g., induction or inhibition) requires more detailed study.
We also note modest changes in the interconnections between
the gene sets in Figures 8A–8D over the time-course. One example
is the disappearance of the link from HSA03320_PPAR_SIGNA-
LING_PATHWAY to HSA00120_BILE_ACID_BIOSYNTH-
ESIS from day 1 to day 2, followed by the reappearance of this
link at day 3. We attribute this behavior to a spurious report of the
link as significant at day 1, since we believe our methods may be
over-sensitive when very few genes are significantly perturbed in a
given contrast (as was the case for day 1). We are currently
investigating ways to improve the robustness of our methods in
reporting links for such scenarios.
Two other noticeable changes over the time series have
immediate biological interpretations. First, the link from NUCLE-
AR_RECEPTORS to HSA03320_PPAR_SIGNALING_PATH-
WAY appears at day 2, which we interpret as a regulatory
relationship reflected in the underlying functional interaction
network and the corresponding up-regulation of the two gene sets.
Second, the link from HSA00071_FATTY_ACID_METABO-
LISM to HSA03320_PPAR_SIGNALING_PATHWAY also
appears at day 2, which we interpret in light of feedback in the
fatty acid metabolic pathway. In the rest of this section, we discuss
the linkages between these three gene sets, anchoring our
discussing on the underlying functional interaction networks on
day 8 (Figures 9 and 10). We divide our discussion into three parts:
interactions of nuclear receptors with cytochrome P450 enzymes,
Figure 5. Context-free BPLN, constructed using the approach of Dotan-Cohen et al. [8]. Colors of gene sets represent perturbation
measured by GSEA for CS versus HM at day 8. Note that these perturbation values did not factor into the computation of the BPLN; we display them
only for the purpose of visual comparison with Figures 1–4.
doi:10.1371/journal.pone.0015247.g005
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metabolism.
Interactions of nuclear receptors with cytochrome
P450s. In Figure 9, the nuclear receptors that contribute to the
linkage between NUCLEAR_RECEPTORS and the HSA03320_
PPAR_SIGNALING_PATHWAY are Hepatocyte Nuclear Factor
4a (Hnf4a), Liver Receptor Homolog-1 (Nr5a2/Lrh1), Liver X
Receptor a (Nr1h3/Lxra), PPARa, Nuclear Orphan Receptor
(Nr1h2/OR-1), and Retinoic acid receptors a, b,a n dc (RXRa and
RXRb, RXRg). The dense network of interactions involving
PPARa, RXRa, RXRb, and Nr1h3 have been incorporated into
STRING from curated pathway databases such as REACTOME
[11].
All these nuclear receptors exhibit increasing perturbation over
time, and interact with CYP7A1, a cytochrome P450 enzymethat is
a member of the PPAR signaling pathway. Note that CYP7A1 itself
shows no significant perturbation until day 8. We discuss the
support in the literature for a subset of the interactions with
CYP7A1. HNF4a has been shown to bind to the promoter regions
of CYP7A1, resulting in up to a nine-fold increase in production of
the CYP7A1 protein in vitro [39]. The literature suggests tenuous
regulatory connections between liver receptor homolog 1 (LRH-1,
or Nr5a2) and CYP7A1. In vitro studies have shown that Nr5a2 both
promotes and represses the expression of CYP7A1 [40,41]. In a
recent study, a knockout of Lrh-1 (Nr5a2) performed selectively in
cells that developed into mouse hepatocytes demonstrated that the
absence of Nr5a2 had little effect on expression of CYP7A1 [42].
Liver X receptors regulate cholesterol and lipid homeostasis in
multiple tissues via two isoforms: LXRa (Nr1h3), which is highly
expressed in liver, and LXRb which is more abundant in adipose
tissue, gut, kidney, and macrophages [43]. In contrast to the
connection between LRH-1 and CYP7A1, LXRa is well known to
Figure 6. Network of functional interactions resulting in the link between V$HNF1_Q6 and HSIAO_LIVER_SPECIFIC_GENES on day
8. In this and subsequent figures of such networks, each node represents a gene, and its color indicates the statistical significance of its perturbation
(up- or down-regulation) in the contrast between CS and HM on the corresponding day. A node’s shape represents its membership within the two
gene sets: a pentagon represents membership in the first gene set (i.e., V$HNF1_Q6), a rectangle represents membership in the second gene set (i.e.,
HSIAO_LIVER_SPECIFIC_GENES), and the house shape represents membership in both gene sets. Nodes with blue (respectively, green) borders are
those genes in the first (respectively, second) gene set that we mention or discuss in the text. An edge connecting two nodes represents a functional
interaction as predicted by STRING. To increase clarity, we do not display interactions between genes within the same set. Abbreviations: HNF1:
annotated with V$HNF1_Q6, LS: annotated with HSIAO_LIVER_SPECIFIC_GENES.
doi:10.1371/journal.pone.0015247.g006
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[44]. Thus, it is surprising that we did not observe significant
perturbation in expression of CYP7A1 until day 8. However, in vitro
studies indicate that CYP7A1 protein exhibits low turnover [35],
raising the possibility that the hepatocytes in both cultures had
ample amounts of the proteins up to day 3.
Another set of contributions to the linkage between these two
gene sets come from interaction of the nuclear receptors Hnf4a and
Nr5a2/Lrh1 with sterol 12a-hydroxylase (CYP8B1), a member of
the PPAR signaling pathway. CYP8B1 catalyzes a fate-determining
reaction in which cholesterol is ultimately converted into the
primary bile acid cholic acid, rather than chenodeoxycholic acid
[35]. The study of selective knockout of Lrh-1 (Nr5a2) in mice [42]
showed that, in contrast to the effect on the expression of CYP7A1,
the knockout caused a significant drop in expression of CYP8B1,
demonstrating a very strong regulatory relationship between Nr5a2
and CYP8B1 [42]. Additionally, strong experimental support for
Hnf4a promotion of CYB8B1 expression exists [45]. Thus, the
expression of CYP8B1 also increases over time, although it lags the
expression of its regulatory receptors Hnf4a and Nr5a2.
Nr5a2 is also predicted to interact with 27-hydroxylase
(CYP27A1), a mitochondrial cytochrome P450 enzyme that is
responsible for a step in the conversion of cholesterol to
approximately 25% of the bile acids in mouse [35]. We observe
an increase in the perturbed expression of CYP27A1 concomitant
to but lagging that of Lrh-1 (Nr5a2). The knockout of Lrh-1 led to
significantly decreased expression of CYP27A1 [42], supporting the
interaction of these two genes.
The role of PPARa. Next, we focus on the role played by
PPARa in the linkage between nuclear receptors and the PPAR
Figure 8. Subgraphs of the CBPLNs involving nuclear receptors and the PPAR signaling, bile acid biosynthesis, and fatty acid
metabolism pathways, on days 1 (A), 2 (B), 3 (C), and 8 (D).
doi:10.1371/journal.pone.0015247.g008
Figure 7. The liver regulates two tightly coupled pathways: bile acid synthesis and fatty acid metabolism. Abbreviations: VLDL: very
low-density lipoprotein, HDL: high-density lipoprotein.
doi:10.1371/journal.pone.0015247.g007
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responsive to fatty acid ligands. PPARs have been divided
among three known subtypes, a, b=d, and c, with each subtype
occurring in distinct tissues and effecting differing biological
responses. Liver cells express PPARa, which is responsible for the
regulation of fatty acid uptake and catabolism [46,47]. In our data,
only PPARa shows increasing expression in CS cultures,
compared to HMs; the other PPARs are not significantly
different between the two culture systems.
In Figure 9, the significantly perturbed members of the PPARa
pathway that PPARa interacts with include Scd1, Fabp1, Apoa2,
Lpl, Acox1, Cpt1a, and CYP7A1. PPARa has been shown to
promote expression of these genes by binding to their upstream
Peroxisome Proliferator Regulatory Element (PPRE) regions as a
heterodimer with RXRa (reviewed in [48]). We note that RXRa
shows significant up-regulation in CS versus HM, as well (Fig. 9).
RXRa has been shown to be particularly highly expressed in the
liver [49]. RXRb, however, tends to have low expression levels
across all tissues [49]. The significant up-regulation of RXRc in
CS versus HM is somewhat puzzling, given that RXRc tends to be
exclusively expressed in the brain, anterior pituitary, and skeletal
muscle [49–51], where it is responsible for triglyceride uptake and
metabolism [52]. We discuss a subset of the interactions involving
PPARa next.
Stearoyl-Coenzyme A desaturase 1 (D9-desaturase, Scd1) is the
main hepatic isoform of SCD. Scd1 helps catalyze the rate-limiting
step in the synthesis of monounsaturated fatty acids, particularly
the production of palmitoleic acid and oleic acid from palmitic
acid and stearic acid, respectively [48,53]. LXRa indirectly
regulates transcription of Scd1 through activation of transcription
of sterol regulatory element binding protein (SREBP) 1c [54,55],
an activator of Scd1 transcription [56,57]. Additionally, LXRa
Figure 9. Network of functional interactions resulting in the link between NUCLEAR_RECEPTORS and HSA03320_PPAR_SIGNA-
LING_PATHWAY on day 8. Abbreviations: NR: annotated with NUCLEAR_RECEPTORS, PPAR: annotated with HSA03320_PPAR_SIGNALING_
PATHWAY.
doi:10.1371/journal.pone.0015247.g009
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element [58]. PPARa has also been demonstrated to directly
activate transcription of Scd1 [59]. Thus, our observation of
increasingly significant changes in expression for LXRa and
PPARa, and a similar trend in Scd1, runs in accordance with
previous studies.
The interaction of Fatty Acid Binding Protein 1 (Fabp1, L-
FABP) with PPARa through protein-protein contacts is thought to
promote the expression of proteins involved in fatty-acid oxidation
and gluconeogenesis [60,61]. Included among these genes is
Fabp1. Thus, it regulates its own expression through PPARa.
Regulation of fatty acid metabolism by nuclear
receptors. The genes in NUCLEAR_RECEPTORS are
responsible for initiating cellular responses to a wide variety of
conditions and for starting appropriate signal cascades. The
nuclear receptors in HSA03320_PPAR_SIGNALING_PATHWAY
are the specific subset responsible for initiating the signaling cascade
l e a d i n gt ot h eb r e a k d o w no fl o n gc h a i nf a t t ya c i d s[ 4 8 ] .T h eg e n es e t
HSA00071_FATTY_ACID_METABOLISM contains the full con-
tingent of genes responsible for the catabolism of fatty acids.
HSA03320_PPAR_SIGNALING_PATHWAY acts as a bridge
between the two general classes of genes, NUCLEAR_
RECEPTORS and HSA00071_FATTY_ACID_METABOLISM.
Figure 9 shows the interactions of individual genes in NUCLEAR_
RECEPTORS with those in HSA03320_PPAR_SIGNALING_
PATHWAY responsible for the upstream processes of fatty-acid
catabolism, including uptake, such as L-FABP (Fabp1) and
early-stage fatty-acid b-oxidation in the peroxisome, such as acyl-
Coenzyme A oxidase 1 (Acox1) [48]. Figure 10 shows the indivi-
dual genes in HSA03320_PPAR_SIGNALING_PATHWAY that
Figure 10. Network of functional interactions resulting in the link between HSA03320_PPAR_SIGNALING_PATHWAY and
HSA00071_FATTY_ACID_METABOLISM on day 8. Abbreviations: PPAR: annotated with HSA03320_PPAR_SIGNALING_PATHWAY, FAM:
annotated with HSA00071_FATTY_ACID_METABOLISM.
doi:10.1371/journal.pone.0015247.g010
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responsibleforlaterstagesofb-oxidationinthemitochondria,suchas
acetyl-Coenzyme A acyltransferase 2 (Acaa2) and hydroxyacyl-
Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/
enoyl-Coenzyme A hydratase b (Hadhb) [48]. Thus, the signals
from NUCLEAR_RECEPTORS are transferred to HSA00071_
FATTY_ACID_METABOLISM via the subset of nuclear receptors
that are members of the PPAR signaling pathway, a chain of events
that we are able to recover in the CBPLNs.
Interpretation of Links in CBPLNs
Keeping the examples of the previous sections in mind, we now
discuss how links in CBPLNs might be interpreted.
Regulatory relationship. Gene set a may contain genes
whose products regulate genes and/or their products in gene set
b. An example is the linkage from NUCLEAR_RECEPTORS
to other gene sets such as HSA03320_PPAR_SIGNALING_
PATHWAY and genes involved in cellular lipid metabolism;
many liver-specific nuclear receptors such as LXRa and HNF4a
regulate critical hepatic processes.
Multi-input motif. Multiple gene sets may link to a gene set
b, suggesting that the expression of genes in b is regulated by genes
in multiple other sets. Such a phenomenon is called a ‘‘multi-input
motif’’ in the case of a gene being regulated by multiple trans-
cription factors [62]. An example is HSIAO_LIVER_SPECIFIC_
GENES and links to this gene set from V$HNF1_Q6 and
NUCLEAR_RECEPTORS.
Feedback. Links that exist in both directions between a and b
may suggest that a regulates b and that b receives a feedback signal
from a. This phenomenon may be observed within CBPLNs when
the link is unidirectional at some time points and bidirectional in
later time points. A specific example is the linkage between bile acid
biosynthesis and HSA03320_PPAR_SIGNALING_PATHWAY,
which is unidirectional on day 2 (Figure 8B) but bidirectional on
days 3 and 8 (Figures 8C and 8D).
Downstream in the signal flow. A link from process a to
process b and another from b and process c may suggest that c lies
downstream of a. An instance of this feature is the link from
NUCLEAR_RECEPTORS to HSA03320_PPAR_SIGNALING_
PATHWAY and the link from HSA03320_PPAR_SIGNALING_
PATHWAY to HSA00071_FATTY_ACID_METABOLISM in
Figure 8B.
Multi-functional gene set. A gene set a that has many
incoming links and/or many outgoing links might be an example
of a multi-functional gene set. A prominent example in our
CBPLNs is the central HSIAO_LIVER_SPECIFIC_GENES
gene set. As we remarked earlier, the links incident on this gene
set suggest what other processes the genes in HSIAO_LIVER_
SPECIFIC_GENES may regulate or be connected to. Clearly,
such a feature depends on how a gene set is defined. For example,
many biological processes in the Gene Ontology such as ‘‘response
to stress’’ are themselves composed of well-defined and
functionally-coherent processes. Similarly, the genes that are
perturbed by a particular stimulus may participate in a wide
variety of processes. CBPLNs can situate such genes in a rich
context within the underlying network of molecular interactions.
Conclusions
We have presented an approach that represents cellular
responses at the granularity of biological processes and connec-
tions among them. Our approach extends the work of Dotan-
Cohen et al. [8] by integrating transcriptional data (the ‘‘context’’)
with functional interaction networks. We focused our analysis on
nearly 20 MSigDB gene sets we had identified as up-regulated in
hepatocyte cultures in an earlier study. CBPLNs revealed
numerous meaningful connections between different biological
processes and gene sets, which we were successful in interpreting
within the context of liver metabolism. Links and local network
features in CBPLNs are generalizations of diverse physiological
phenomena such as regulation, feedback, and downstream signal
flow from the gene/protein level to the scale of biological
processes.
Our approach is a complement to a suite of methodologies that
integrate physical, signaling, regulatory, and functional networks
with measurements of molecular profiles such as transcriptional,
proteomic, or metabolic data to compute the response network, which
may be defined as the sub-network of interactions that are
perturbed in a particular condition. A wide variety of methods
have been developed for computing such response networks [63–
67]. Response networks are typically interpreted by computing
which biological processes are enriched in them. In contrast,
rather than compute the entire response network, we focus on
discovering connections between perturbed biological processes.
Since response networks can include genes without any annota-
tions, they can be used to predict biological processes to which
unannotated genes belong [68]. In contrast, only genes annotated
to some biological process can contribute to CBPLNs. A detailed
comparison of CBPLNs to response networks and the develop-
ment of methods that combine both approaches will be the focus
of future research.
Generalizing our approach to the entire spectrum of MSigDB
gene sets or to the set of all biological processes in the Gene
Ontology raises several interesting challenges. First, gene sets can
have considerable overlap, leading to redundant links. Second,
scaling this approach up to thousands of gene sets may result in
tens to hundreds of thousands of links that are deemed to be
statistically significant. This deluge of links will be hard to
interpret. Third, it will be challenging to computationally scale our
permutation-based sampling to the large number of process pairs
we will have to test. We are currently investigating these issues.
In this work, we computed CBPLNs for two conventional
hepatocyte culture systems. Three dimensional liver mimics
[69,70] and microscale co-culture systems [71] have shown
improved retention of hepatic phenotype over conventional
systems. In the future, we plan to apply CBPLNs to liver mimics
and co-culture systems in order to obtain insights into the inter-
cellular signaling mechanisms that confer improved hepatic
phenotype. More generally, our approach may provide a novel
route to explore, analyze, and interpret cellular responses to
internal and external cues.
Materials and Methods
Measuring perturbation from gene expression data
We applied Linear Models for Microarray Data (LIMMA) [72]
to the DNA microarray data to compute expression p-values
indicating the differential expression of each gene for each of the
four contrasts shown in Table 1.
Scoring a link between a pair of processes
We first present the approach developed by Dotan-Cohen et al.
to identify linkages between biological processes [8]. Given an
intracellular interaction network for an organism and Gene
Ontology annotations for the genes in those networks, Dotan-
Cohen et al. compute what they term a Biological Process Linkage
Network (BPLN). Informally, given two biological processes, they
defined the first process as being linked to the second process if
genes annotated by the first process interact with a significant
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such links are directed. The resulting output of the algorithm by
Dotan-Cohen et al. is, for each ordered pair of processes, the
probability that the first process is linked to the second.
Formally, let F be the set of all biological processes. We seek
to ask ‘‘Given two processes a,b[F,i sp r o c e s sa linked to process
b?’’ More specifically, of the genes that are neighbors of those
annotated by a, are many more annotated with b than would be
expected by chance? Let V be the set of all genes in an organism.
Let Va(V be the set of genes annotated by process a[F,a n dl e t
the universe U~
S
a[F Va, be the set of all genes annotated by at
least one process in F.L e tG(U,E) denote an undirected
interaction graph where E is the set of undirected edges (u,v),
each representing an interaction between genes u,v[U.W e
define the set Na as the set of genes v that meet the following
criteria:
1. gene v neighbors at least one gene u annotated with a
2. gene v is not annotated with a.
In other words,
Na~fv : V(u,v)[E, u[Va, v6[Vag,
Next, we define e N Nab~Na\Vb, i.e., the set of genes that are
neighbors of genes annotated with a, are not annotated with a
themselves, and are annotated with process b. We define the link
p-value p(a,b) as the probability that, if we selected a set X of DVbD
genes uniformly at random from U, the set Na\X would contain














If this link p-value is significant at some cutoff a, we conclude that
process a is linked to process b.
Extending the score to include transcriptional data and
interaction weights
With this background, we extend the formulation of BPLN to
take transcriptional measurements and interaction weights into
account. For each interaction (u,v) in the graph G(U,E), we use
wuvw0 to denote its weight. The larger the weight of an
interaction, the larger is our belief that u and v indeed interact
functionally in the cell. We define a scoring function s(v) : V?R
z
that maps genes to a non-negative real number representing their
degree of perturbation in a given biological context (e.g., CS day 8
versus HM day 8). In this work, we compute s(v) as absolute value
of the logarithm of the LIMMA p-value of the gene. Given
processes a and b, we first define a score t(v,a) : U?R
z.
The function t measures the contribution of the neighbors of v
annotated with term a based on their perturbation. Ideally, if at
least one neighbor of v that is annotated with a is highly perturbed,
we desire that t(v,a) take a high value. On the other hand, if no
such neighbor of v is highly perturbed, we desire that t(v,a) take a
small value. Naturally, the weights of the interactions should also
play a role in t(v,a). Accordingly, we define
t(v,a)~maxfwuvs(u) : (u,v)[E, u[Vag,
i.e., t(v,a) is the maximum weighted score of all neighbors of node
v that are annotated with process a.
We define the contextual linkage score s(a,b) between processes a





Figure 11 contains a toy example that illustrates these concepts.
Thus, a node v annotated by a makes a large contribution to the
contextual linkage score s(a,b) if v shows a high amount of
perturbation in a particular context and if the neighbors of v
annotated by a also show a high amount of perturbation. If we
have many such nodes v, then s(a,b) itself will be large. Note that
if we set s(v)~1 for all v[U and if all edges have weight 1, then
s(a,b) is equal to the size of ab, identical to the score computed by
the original BPLN algorithm.
In this formulation, some pairs of processes may have a high
contextual linkage score even if all genes were perturbed by the
same amount. To account for this possibility, we compute a
normalized score s (a,b)~s(a,b){s’(a,b), where s’(a,b) is a
background score computed in the same manner as s(a,b), but,
after setting the gene perturbation score s(u) equal to the average
expression s~
P
u[U s(u)=DUD for all genes u in U. Thus, s’(a,b)
represents the score for the link between processes a and b if all
genes had the average expression score.
Assessing the statistical significance of links
Since the contextual linkage score is a weighted generalization
of the statistic measured by Dotan-Cohen et al. it is unclear how to
compute its statistical significance analytically. Therefore, we use
two different approaches in order to assess the significance of the
observed score s(a,b) empirically.
1. The first approach is an empirical version of the test performed
by Dotan-Cohen et al. [8]: what is the probability that we
would observe a score s(a,b) or more if we were to randomly
select the nodes annotated with b? Specifically, we repeatedly
select a set X of size DVbD uniformly at random without
replacement from U and calculate s(a,b) for each of these
random selections. After performing the step 10,000 times, we
Figure 11. Calculating the links score s(a,b) in an example
network. Nodes with bold borders (w, x, and y) represent genes in e Nab.
Bold edges indicate the interactions contributing to s(a,b).
doi:10.1371/journal.pone.0015247.g011
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observed value of s(a,b) as the link p-value p(a,b).
1. Two different processes may annotate some genes in common.
To preserve this property even in the random selections of the
set X over different processes, we adopt the following
approach: we construct a bipartite graph H in which a node
is a gene or a biological process and an edge connects a gene to
a biological process it is annotated with. We randomly permute
the labels of the genes in this graph. To generate a random set
X of size DVbD, we simply select the genes annotated with b in
the bipartite graph with randomized gene labels. These steps
create a randomized set of annotations that satisfy two
properties: (a) every process annotates the same number of
genes as in the original set of annotations, and (b) if k genes are
annotated by each process in a set of processes P(F, then
these processes co-annotate exactly k genes in the randomized
dataset as well.
2. The second approach accounts for the role played by the
interactions between the genes in Va and genes in Vb.
Therefore, we generate a graph G’(U,E’) with the property
that each node v[U has the same degree in G’ and G.W e
measure the contextual linkage score between a and b with
respect to G’. We generate G’ 10,000 to build a null
distribution for the contextual linkage score, and compute the
link p-value p(a,b) as before.
2. To construct G’, we follow the ‘‘edge-swap’’ approach [73]. We
begin with the set of edges E’~E and modify the edges in E’
with pairwise edge swaps. For each edge swap, we first select a
pair of edges (u,v),(x,y)[E’. We then select, with equal
probability, either (u,y),(x,v) or (u,x),(v,y) (i.e., the edges
created by swapping the endpoints of the original pair of edges)
as a candidate edge pair. If either candidate edge already exists
in E’ or creates a self-loop, we retain the original pair of edges
in E’, i.e., we do not perform the edge swap. Otherwise, we
remove the original edges (u,v),(x,y) from E’ and insert the
new edges into E’. In total, we perform kDED edge-swap events
to create a randomized graph G’, where k is a user-defined
parameter. In this work we used k~10.
We use the method of Benjamini and Hochberg [20] to correct
for testing multiple hypotheses, while ensuring that the corrected
link p-values are monotonic [74]. For either approach, if
p(a,b)ƒ0:01, we say that term a is linked to b in the given
biological context.
Supporting Information
File S1 File S1 is in tab-separated values format. It contains
results of comparisons on the number of links identified to be
significant under the two hypothesis tests, as well as under the
original BPLN algorithm by Dotan-Cohen, et al. [8], which does
not consider gene expression data. Six tables are given for different
pairwise comparisons of hypothesis tests. In the table headers,
‘‘gene set’’ indicates testing the significance of a link when
compared to a distribution of scores calculated from randomized
annotations, ‘‘network’’ indicates testing the significance of a link
when compared to a distribution of scores calculated from a
randomized network, ‘‘normalization’’ indicates the scores were
normalized by deducting the score calculated for averaged
expression, and ‘‘bpln’’ indicates testing the significance using
the original BPLN algorithm. Column headers of tables are
defined as follows: ‘‘day’’ indicates the time point of the contrast;
‘‘in both’’ indicates the number of links found to be significant in
the two compared hypothesis tests (e.g., gene set randomization
and network randomization); ‘‘first only’’ indicates the number of
links found significant under the first hypothesis test (e.g., gene set
randomization); ‘‘second only’’ indicates the number of links found
significant under the second hypothesis test (e.g., network
randomization); ‘‘neither’’ indicates the number of links not found
significant under either hypothesis test; ‘‘intersection significance’’
indicates the significance of the number of links found significant
under both hypothesis tests versus what would be expected by
chance, as assessed under Fisher’s Exact Test.
(TSV)
File S2 File S2 is in tab-separated values format. It contains
results of comparisons between the two different hypothesis tests,
as well as the original BPLN algorithm by Dotan-Cohen, et al. [8].
Four sets of tables appear indicating the comparison of results at
different cutoffs for considering a link to be significant. The
header of each set indicates the cutoff used: 0.005, 0.01, 0.05, or
0.1. In each set of tables, the first set is the pairwise comparison
under the two hypothesis testing methods of gene set randomi-
zation and network randomization, using normalization. The
column headers for this table are defined as follows: ‘‘Gene set
randomization normalized’’ indicates the number of links found to
be significant under gene set randomization with normalization;
‘‘Network randomization normalized’’ indicates the number of
links found to be significant under network randomization with
normalization; ‘‘Intersection’’ indicates the number of links found
significant under both forms of randomization; and ‘‘Jaccard
index’’ indicates the ratio of the size of the intersection of the sets
of links significant under the two tests to the size of their union. In
the second table of each set, the results under the original BPLN
algorithm are compared to those of the two hypothesis tests. The
column headers for this table are defined as follows: ‘‘BPLN’’
indicates the number of links found significant under the original
BLPN algorithm; ‘‘Gene set randomization normalized’’ and
‘‘Network randomization normalized’’ are identical to the first
table; ‘‘Intersection’’ indicates the number of links found
significant under the original BPLN algorithm and the respective
hypothesis test (e.g., under gene set randomization); ‘‘Jaccard
index’’ indicates the ratio of the size of the intersection of the sets
of links found significant under BPLN and the respective
hypothesis test to the size of the union.
(TSV)
File S3 File S3 contains scatter plots of link p-values for links
found to be significant (p-value ƒ0:01) by least one of the
hypothesis tests (based on gene set randomization or on network
randomization) with normalization. Each plot corresponds to a
single day. Each point on a plot corresponds to one pair of
processes, with the x-coordinate being the p-value from gene set
randomization and y-coordinate representing the p-value from
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